Physician profile
Jonathan M Lee
NPI 1003917626
$9,299.66
in general payments reported to CMS, 2019-2025
41 companies · $1,005 in 2025
The $1,005 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,367 · 2020: $959 · 2021: $1,650 · 2022: $1,631 · 2023: $1,290 · 2024: $1,397 · 2025: $1,005.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,681 · Education: $11.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,680.72 |
| Education | $11.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,743.17 | 2019-2025 | Breztri, Farxiga, Lokelma |
| Abbvie INC. | $1,258.15 | 2021-2025 | |
| Amgen INC. | $906.01 | 2019-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $687.99 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $634.85 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $614.56 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $524.89 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $297.06 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $247.61 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $239.32 | 2019-2025 | Jardiance |
| Antares Pharma, INC. | $236.83 | 2019-2025 | Xyosted |
| Takeda Pharmaceuticals U.S.A., INC. | $182.87 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $180.64 | 2022 | |
| Merck Sharp & Dohme LLC | $180.13 | 2019-2023 | Pneumovax 23, Gardasil 9, Vaxneuvance |
| Allergan, INC. | $147.72 | 2019-2020 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.